Skip to main content
. 2016 Apr 26;16(4):e35577. doi: 10.5812/hepatmon.35577

Table 1. Estimations of the Prevalence of HBV Infection in the General Population of Iran and its Provinces.

Province Study’s first author (year of publication) Year of Study Total No. Male No. HBV Prevalence estimates % (95% CI) Reference
Charmahal and Bakhtiari Moezzi (2014) 2012 - 2013 3000 1111 1.3 (0.9 - 1.7) (30)
East Azarbaijan Bayat-Makou (2003) 2000 381 ND 1.2 (0.1 - 2.3) (31)
Golestan
Study 1 Pourshams (2004) 2003 1035 438 4.3 (3 - 5.5) (24)
Study 2 Roshandel (2007) 2004 - 2005 1850 877 8.9 (7.6 - 10.2) (14)
Study 3 Merat (2009)a 2006 1896 607 5.1 (4.1 - 6.1) (23)
Total 6.1 (3.5 - 8.7)
Hamadan
Study 1 Amini (1993) 1989 4930 1649 2.5 (2.1 - 2.9) (25)
Study 2 Alizadeh (2006) 2003 1824 1025 2.3 (1.6 - 3) (12)
Total 2.4 (2.1 - 2.8)
Hormozgan Merat (2009)a 2006 1455 658 2.7 (1.9 - 3.5) (23)
Isfahan Nokhodian (2009) 2006 816 388 1.3 (0.5 - 2.1) (32)
Kermanshah Alavian (2012) 2010 1979 990 0.7 (0.4 - 1.1) (33)
Kordestan Alavian (2012) 2010 1613 548 0.8 (0.4 - 1.2) (34)
Mazandaran Keyvani (2014) 2008 - 2011 6146 3472 0.9 (0.7- 1.2) (35)
Qom Ghadir (2012) 2010 3666 1709 1.3 (0.9 - 1.7) (36)
Razavi Khorasan
Study 1 Farhat (2003) 1998 4528 ND 3.6 (3.1 - 4.1) (13)
Study 2 Fathimoghaddam (2011) 2009 1652 794 1.4 (0.8 - 2) (26)
Study 3 Shakeri (2013) 2010 - 2011 3198 1021 1 (0.7 - 1.3) (27)
Total 2 (0.4 - 3.6)
Sistan and Baluchestan
Study 1 Shahramian (2009) 2008 458 221 3.5 (1.8 - 5.2) (28)
Study 2 Salehi (2012) 2010 3989 1835 3.4 (2.8 - 4) (29)
Total 3.4 (2.9 - 3.9)
Southern Iran Abedi (2011) 2008 - 2009 4087 1292 1.5 (1.1 - 1.9) (37)
Tehran Merat (2009)a 2006 2327 968 2.3 (1.7 - 2.9) (23)
National
Study 1 Zali (1996) 1991 39841 ND 1.7 (1.6 - 1.8) (10)
Study 2 Zali (2005) 1999 46631 ND 1.7 (1.6 - 1.8) (11)
Total 1.7 (1.6 - 1.8)
Overall 2.2 (1.9 - 2.6)

Abbreviation: ND, not determine.

aThis study was conducted in Golestan, Hormozgan, and Tehran provinces.